A-Med Medical Supply Division has been acquired by Byram Healthcare Centers, Inc.
A-Med Health Care (A-Med) has sold its Medical Supplies Division to Byram Healthcare Centers, Inc. (Byram), a wholly owned subsidiary of Mediq NV. The acquisition represents an EBITDA multiple of approximately 7.5x, excluding synergies.
Founded in 1982 and headquartered in Huntington Beach, California, A-Med is one of the leading distributors of incontinence and urology supplies in the California market serving Medicare, Medicaid / Medi-Cal and managed care patients.
Byram operates as a US subsidiary of Mediq NV, an international company delivering medical devices, pharmaceuticals and related care services. Mediq delivers via three channels: direct to people's homes (Direct), to professional customers such as hospitals, nursing homes and GPs (Institutional) and via Mediq Pharmacies. Mediq operates in 15 countries and has its head office in Utrecht, the Netherlands. This acquisition will establish Byram as a leading provider of medical supplies in the Californian home care market.
A-Med Health Care is a specialty pharmacy providing advanced medications, infusions, supplies, and services to patients living with complex conditions. The company provides support for patients suffering from conditions such as Cystic Fibrosis, HIV/AIDS, Multiple Sclerosis, organ transplants and paraplegia. A-Med Health Care, founded in 1982 and with approximately 200 employees, services patients all across the country.
Oaklins' team in Los Angeles acted as the exclusive financial advisor to A-Med in connection with this asset sale. The transaction was facilitated by Oaklins' team in the Netherlands who identified and contacted Mediq on behalf of the American team. This transaction once again highlights our ability to close deals worldwide.
Talk to the deal team
Gary S. Rabishaw
Oaklins Intrepid
Eduard Bagdasarian
Oaklins Intrepid
Jeremiah Mann
Oaklins Intrepid
Related deals
Bayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn moreCombo Group has been acquired by Heniff Transportation Systems
US-based Heniff Transportation Systems has acquired Combo Group. With this transaction, Heniff Transportation Systems immediately expands its presence in the European market, in line with its strategy to grow bulk transportation operations across the region.
Learn moreVivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
Learn more